The right therapy.At the right moment.
Autologous NK cell therapy designed to target residual cancer.
Here’s an interesting question.
01The window
Why does cancer come back so often once it’s been killed?
Even when most of the cancer is eliminated, the few cells left behind, known as minimal residual disease, can bring it back.
Here’s what’s happening.
Fig. 1 · The treatment window
The patient is diagnosed with a high disease burden.
Treatment kills most of the cancer, leaving minimal residual disease.
But if a few cells survive, the cancer comes back.
NOK is designed to target those last cells.
Illustrative
A clean-up crew for residual disease.
NOK is developing an immune cell therapy from the patient’s own NK cells, designed to clear the cancer cells that other treatments leave behind.